anonymous
Guest
anonymous
Guest
this is completely true. All things are on a need to know basis. And when I ask/pry my manager with questions, they are wondering why I am asking them.
SO, what makes you think your manager knows? Hmmmm……
this is completely true. All things are on a need to know basis. And when I ask/pry my manager with questions, they are wondering why I am asking them.
Everyone excited about Ongentys? A Quick Look at my data showed me that I have less than a dozen RXs in my territory. Those of you who have writers already are in for massive pay days! The rest of us….not so much. Our only hope is that this Jet Fuel is priced like regular gas. But do we honestly have any confidence in our Managed Markets team? Have they ever gotten a big win for Rytary? They certainly didn’t for Lyvispah and have nothing to do with Unithroid.
The Miami rep. sure was brave or stupid with her question uhhh statement about the generic version of Ongentys. It really was a buzz kill. Let’s see: we have a generic for Rytary, Emverm, Ongentys, and Unithroid. Did you see the look on Joe’s face? Not a smart move for Lilian. You all better smile and sip the KookAid or your ass is grass.
She’s the Puerto Rico rep. She has probably 5-6 COE wins. I’m not sure what she’s complaining about. She has 0 cost issues with Rytary Put her in Miami or Denver or anywhere else she’s not nearly as successful
I just hope they price it competitively. But I don’t trust Derek to get anything accomplished. And if they price it less than Rytary providers will go there before Rytary. Hopefully they give us more time than they gave the Spasticity folks!
Smoke & Mirrors….. Amneal makes money off the brands and money off the generics of the brands. It is a win win for the company.
There’s no generic for Rytary. There is a generic COMPT but don’t know if Amneal males one. I did hear that we make Unithroid AND generic unithroid. Which is a win win for sure!
Rytary goes generic in 2025 (Actavis). Amneal has been holding off a generic NDA
Doctors don't prescribe Rytary primarily due to cost, not because of dosing issues. If Rytary were more affordable, they would take the time to figure out the dosing. When Rytary becomes generic, there will be no reason to prescribe IPX, or at least not before generic Rytary. It's possible that if Rytary fails, they will turn to IPX, however, that drug is expected to be expensive and likely still difficult to dose. Ongentys is not a new product, not really expecting big things from that drug. 2024 will be the year of turnover company wide.
Do the upper management team not know this is the Holiday Season? Most of us are on PTO yet they continue to push stuff they claim as urgent down our throats I mean you give me 72 hours to make reservations for the NSM but the lady actually in charge of that is also on PTO. This place is crazy!
What products are these professional health positions for? Seeing a few in major cities. What products?
Not surprised, they are micro managing everything and making life miserable! The company does not pay people what they are worth yet they expect you to go to jump through hoops.